You are here

Article Text

Article menu
Download PDFPDF
Editorial
HAART, CMV retinitis, and monitoring
  1. MARC D DE SMET
  1. Department of Ophthalmology, University of Amsterdam Academic Medical Center, Amsterdam, Netherlands

    https://doi.org/10.1136/bjo.85.7.766

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      With the advent of highly active antiretroviral therapy (HAART), the care of AIDS patients has drastically changed. Patients achieve partial immune reconstitution, appear capable of coming off medication and in many cases do not seem to have recurrences of cytomegalovirus (CMV).12 However, a risk period remains for the first few months after initiating HAART.3 The length of this period remains debatable, as does the best approach to monitor patients …

      View Full Text

      Linked Articles